Our results here show that IL-1R blockade does not improve systolic function or reverse cardiac arrhythmias, indicating IL-1β/IL-1R signaling is not involved in its maintenance, as it is in other diseases (16, 17). This evidence concerns the gene IL1B and cardiac arrhythmia.